http://www.bing.com/news/search?q=king+pharma&form=QBNT&format=rssSearch resultshttp://www.bing.com/rsslogo.gifhttp://www.bing.com/news/search?q=king+pharma&form=QBNT&format=rssCopyright \xc2\xa9 2026 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Bing results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a34ae0920bf416bb6118cee2337ef0d&url=https%3a%2f%2fnjbiz.com%2fking-pharma-palatin-to-develop-sexual-dysfunction-drug%2f&c=17009278034307009741&mkt=en-usNJBIZ, New Jersey’s leading business journal, provides 24/7 business news coverage and events honoring top business professionals.Mon, 08 Aug 2005 17:00:00 GMTNJBIZhttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a34ae0920bf416bb6118cee2337ef0d&url=https%3a%2f%2fwww.nbcnews.com%2fid%2fwbna39721543&c=14946119107511605323&mkt=en-usSAN DIEGO, Oct. 18, 2010 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that an investor in King Pharmaceuticals, Inc. (NYSE:KG) filed a lawsuit in State Court against the King ...Mon, 18 Oct 2010 07:15:00 GMTNBC Newshttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a34ae0920bf416bb6118cee2337ef0d&url=https%3a%2f%2fwww.benzinga.com%2f10%2f12%2f737945%2fking-pharma-resubmits-remoxy-nda-analyst-blog&c=2554239633594447380&mkt=en-usKing Pharmaceuticals Inc. (KG) and partner Pain Therapeutics Inc. (PTIE) recently announced that they have resubmitted a new drug application (NDA) to the US Food and Drug Administration (FDA) for ...Wed, 29 Dec 2010 01:45:00 GMTBenzinga.comhttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a34ae0920bf416bb6118cee2337ef0d&url=https%3a%2f%2fwww.reuters.com%2farticle%2fbusiness%2fhealthcare-pharmaceuticals%2fking-pharma-options-up-on-takeover-talk-analysts-idUSN30307387%2f&c=17102386261016447059&mkt=en-usCHICAGO, Nov 30 (Reuters) - King Pharmaceuticals Inc option volume surged on Friday fueled by speculation that the drug maker may be acquired, according to several options analysts. Pfizer Inc , the ...Fri, 30 Nov 2007 15:03:00 GMTReutershttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a34ae0920bf416bb6118cee2337ef0d&url=https%3a%2f%2fwww.fiercebiotech.com%2fbiotech%2fking-pharmaceuticals-responds-to-alpharma-inc&c=3527065470143650814&mkt=en-usKing Pharmaceuticals Responds to Alpharma Inc. BRISTOL, Tenn.--(BUSINESS WIRE)--King Pharmaceuticals, Inc. (NYSE: KG) today issued the following statement in response to an announcement by Alpharma ...Fri, 26 Sep 2008 08:02:00 GMTFierceBiotechhttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a34ae0920bf416bb6118cee2337ef0d&url=https%3a%2f%2fwww.benzinga.com%2f10%2f12%2f720806%2fking-pharma-files-nda-for-pain-drug-analyst-blog&c=4259553259300011501&mkt=en-usKing Pharmaceuticals, Inc. (KG) and partner Acura Pharmaceuticals, Inc. (ACUR) recently announced the submission of a new drug application (NDA) for their opioid candidate, Acurox. The companies are ...Tue, 21 Dec 2010 00:30:00 GMTBenzinga.comhttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a34ae0920bf416bb6118cee2337ef0d&url=https%3a%2f%2fwww.fiercebiotech.com%2fbiotech%2fking-pharmaceuticals-proposes-acquisition-of-alpharma-for-33-per-share-cash&c=12784613276847231119&mkt=en-usBRISTOL, Tenn.--(BUSINESS WIRE)--King Pharmaceuticals, Inc. (NYSE: KG - News) announced today that it has submitted to the Board of Directors of Alpharma Inc. (NYSE: ALO - News) a proposal to acquire ...Fri, 22 Aug 2008 01:42:00 GMTFierceBiotech